Neurology News

Bendit Technologies announced it received FDA 510(k) clearance for its steerable microcatheter platform for treatment in the neurologic, peripheral and coronary vasculature.

Younger patients with diffuse midline glioma experienced prolonged clinical improvement after receiving an investigational chimeric antigen receptor T-cell therapy, study results demonstrated.

SEATTLE — Trudhesa was effective in treating migraines of varying severity, a speaker said at the 2022 American Academy of Neurology annual meeting.

SEATTLE — Although advancements have been made in immune checkpoint inhibitors, tumors such as glioblastoma present a roadblock to successful therapy, according to a presenter at the 2022 American Academy of Neurology annual meeting.

Self-reported symptoms of anxiety and depression were higher among men aged 50 years and older with vision impairment, compared with those with normal vision, study findings showed in International Health.

SEATTLE — Patients with acute ischemic stroke need access to lifesaving thrombectomy in all areas of the world, a speaker said at the 2022 American Academy of Neurology annual meeting.

Together Senior Health, a digital therapeutics and cognitive health firm, has announced the launch of its cognitive health platform, which it hopes will reduce the impact of memory loss in those with Alzheimer’s disease and dementia.

SEATTLE — Clinicians should consider disease-modifying therapeutics when treating patients with rare pediatric disorders, according to an expert at the 2022 American Academy of Neurology annual meeting.

Patients with Alzheimer’s disease who are treated with lecanemab have shown the potential to reaccumulate brain amyloid after removal of the drug, a speaker said at the 2022 American Academy of Neurology annual meeting.

SEATTLE – Inebilizumab was shown to be safe and effective in preventing relapses in individuals with neuromyelitis optica spectrum disorder, a speaker said at the 2022 American Academy of Neurology annual meeting.